UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

A study of vistusertib in combination with selumetinib in patients with advanced cancers: TORCMEK phase Ib results.

Schmid, P; Forster, MD; Summers, YJ; Good, J; Sarker, S-J; Lim, L; Mousa, K; (2017) A study of vistusertib in combination with selumetinib in patients with advanced cancers: TORCMEK phase Ib results. Presented at: 42nd European-Society-for-Medical-Oncology Congress (ESMO), Madrid, Spain.

Full text not available from this repository.
Type: Conference item (UNSPECIFIED)
Title: A study of vistusertib in combination with selumetinib in patients with advanced cancers: TORCMEK phase Ib results.
Event: 42nd European-Society-for-Medical-Oncology Congress (ESMO)
Location: Madrid, Spain
Dates: 08 - 12 September 2017
DOI: 10.1200/JCO.2017.35.15_suppl.2548
Language: English
Keywords: Science & technology, life sciences & biomedicine, oncology.
UCL classification: UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > UCL Medical School
URI: http://discovery.ucl.ac.uk/id/eprint/10032622
Downloads since deposit
0Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item